Hipertansif Acillere Yaklaşım

Yazarlar

İdris Oruç
https://orcid.org/0000-0003-0396-7498

Özet

Hipertansif acil, sistolik ve diyastolik kan basıncındaki ciddi yükselmeyle birlikte akut veya ilerleyici hedef organ hasarının bulunması durumudur ve kan basıncının dakikalar içinde düşürülmesini gerektirir. Hedef organ hasarları arasında akut böbrek hastalığı, miyokard infarktüsü, pulmoner ödem, sol ventrikül yetmezliği, aort diseksiyonu, hipertansif ensefalopati, inme ve mikroanjiopatik hemolitik anemi yer alabilir. Hastalarda baş ağrısı, bulantı, kusma ve bulanık görme gibi hafif semptomlardan yaşamı tehdit eden tablolara kadar geniş bir klinik görülebilir. Patofizyolojide basınç artışına bağlı endotel hasarı, iskemi ve fonksiyon bozukluğu rol oynar. Değerlendirmede fizik muayene, kan testleri, kardiyak belirteçler, idrar analizi, fundoskopi, EKG, akciğer grafisi ve ultrasonografi yapılmalıdır. Tedavide temel amaç hedef organ disfonksiyonunu ve komplikasyonları önlemektir. İlk saatte kan basıncında maksimum %20-25 azalma sağlanmalı, 2-6 saat içinde basınç 160/100 mmHg seviyesine indirilmelidir. Serebrovasküler olaylar ve aort diseksiyonu bu hedeflerde istisna oluşturur. Tedavide hastanın durumuna ve komorbiditelerine göre kaptopril, nifedipin, amlodipin, labetalol, esmolol, fenoldopam, sodyum nitroprussid, nitrogliserin, hidralazin, furosemid, klonidin ve fentolamin gibi parenteral veya oral antihipertansif ilaçlar tercih edilir.

Referanslar

Torun D,Sezer S,Özdemir FN.Hipertansif acillere yaklaşım.Turkiye Klinikleri J Nephrol 2008, 3

Williams B, Mancia G, Spiering W, et al; 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041.

Vilela Martin JF, Higashiama E´, Garcia E,et al. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol. 2004;83:125–36.

Zampaglione B, Pascale C, Marchisio, et al. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension. 1996;27:144–7.

Karras DJ, Kruus LK, Cienki JJ, et al. Evaluation and treatment of patients with severely elevated blood pressure in academic emergency departments: a multicenter study. Ann Emerg Med. 2006;47:230–6

Vidt DG. Cur rent con cepts in treatment of hypertensive emergencies. Am Heart J 1986; 111:220-5.

She a S, Mis ra D, Ehr lich MH, at al. Predisposing factors for severe, un -controlled hyperten sion in an inner-city minority population. N Engl J Med 1992;327: 776-81.

Ault MJ, Ellrodt AG. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med 1985; 3:10-5

Las se gu e B, Gri end ling KK. Reactive oxygen species in hypertension: an update. Am J Hyper tens 2004; 17:852-60

Wu HP, Yang WC, Wu YK,at al. Clinical significance of blood pressure ratios in hypertensive crisis in children. Arch Dis Child. 2012;97(3):200-5.

Rey E, Le Lo ri er J, Bur gess E,at al. Report of the Canadian Hypertension Society Consen sus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997;157:1245 54.

Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122:311-28

Qureshi AI, Bliwise DL, Bliwise NG,at al. Rate of 24 hour blood pressure decline and mortality after spontenous intraserebral hemorrhage: A retrospective analysis with a random effects regression model. Crit Care Med 1999; 27:480-5.

Munoz S, Martin N, Arruga J. Malignant hypertension :ocular manifestations. Scientific World Jour nal 2006;6:122-4.

Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949–62.

van den Born BJH, Beutler JJ,at al, Dutch guideline for the management of hypertensive crisis—2010 revision. Neth J Med. 2011;69:248–55.

Kaya A, Tatlısu MA, Kaplan Kaya T, at al. Hipertansif krizde sublingual ve oral kaptopril. J Emerg Med. 2016; 50: 108–15.

Grossman E, Messerli FH, Grodzicky T,at al.A moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies. JAMA. 1996;276(16):1328–31.

Donnelly R, Meredith PA, Miller SHK, at al. Pharmacodynarnic modeling of the antihypertensive response to amlodipine. Clin Pharmacol Ther. 1993;54:303–10.

Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68:283–97.

Marx P, Reid D. Labetalol infusion in acute myocardial infarction with systemic hypertension. Br J Clin Pharmacol. 1979;8:233S–8S.

Shi Y, Zalewski A, Bravette B, at al. Selecti ve dopamine-1 receptor agonist aug ments regional myocardial blood flow: comparison offenol dopam and dopamine. Am Heart J 1992;124:418-23.

Shusterman NH, Elliott WJ, White WB. Fenol -dopam, but not nitroprusside, improves renal func tion in severely hypertensive patients with impaired renal function. Am He art J 1993;95:161-8.

Khot UN, Novaro GM, Popović ZB, at al Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003 May 1;348(18):1756-63.

Kondo T, Brock MBH. Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation. Jpn Heart J. 1984;25:231–7.

Niknahad HOP. Involvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicity. Biochem Pharmacol. 1996;51:1031–9.

Maloberti A, Cassano G, Capsoni N,at al Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room. High Blood Press Cardiovasc Prev. 2018 Jun;25(2):177-189.

Ludden TM, Shepherd AMM, McNay JL, at al. Hydralazine kinetics in hypertensive patients after intravenous administration. Clin Pharmacol Ther. 1980;28:736–42.

Vuylsteke A, Vincent JL, Payen D, et al. Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for studying the treatment of acute hypertension (Euro-STAT) registry. Crit Care. 2011;15:1–9.

Gelecek

20 Mayıs 2021

Lisans

Lisans